|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.32 HKD | +1.65% |
|
+3.79% | -5.30% |
| 03-16 | Abbisko Doses First Patient in Liver Cancer Drug Trial | MT |
| 03-11 | Abbisko Drug Receives Rare Pediatric Designation in U.S. | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bullish |
| Resistance | 13.46 | 14.73 | 18.21 |
| Spread/Res. | -8.47% | -16.36% | -32.34% |
| Spread/Supp. | +11.80% | +11.80% | +12.00% |
| Support | 11.02 | 11.02 | 11 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 2256 Stock
- Charts Abbisko Cayman Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition